cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5281/zenodo.5921060
title: Tropical multi-datasource and multi-frequency temperature anomalies (TROPTEMP)

description: Multi-frequency temperature anomalies in the tropical region computed from the datasets: CPC, ECCO2_JPL cube92, J-OFURO, MODIS-Aqua, University of Delaware and Windsat.
description: We wish to express our thanks to the TRIATLAS project (Tropical and South Atlantic climate-based marine ecosystem predictions for sustainable management), to Tropical Atlantic Interdisciplinary Laboratory on physical, biogeochemical, ecological and human dynamics (IJL TAPIOCA) and the Brazilian Research Network on Global Climate Change (Rede CLIMA).
description: {"references": ["Humberto L. Varona. (2021). mNC: A tool for Oceanographers and Meteorologists to easily create their NetCDF files using Matlab (1.0). Zenodo. https://doi.org/10.5281/zenodo.5572749", "Humberto L. Varona. (2021). CalcPlotAnomaly: Matlab function set for the calculation and plotting of anomalies (1.01). Zenodo. https://doi.org/10.5281/zenodo.5576889"]}
DOI: 10.5517/ccdc.csd.cc2507t8
title: CCDC 1996239: Experimental Crystal Structure Determination

description: Related Article: Issa Yavari, Ramin Mohsenzadeh, Parisa Ravaghi|2022|J.Org.Chem.|87|2616|doi:10.1021/acs.joc.1c02572
DOI: 10.5281/zenodo.6339707
title: DeepCAD-RT dataset: zebrafish optic tectum neurons

description: DeepCAD-RT dataset: zebrafish optic tectum neurons
DOI: 10.5281/zenodo.6339706
title: DeepCAD-RT dataset: zebrafish optic tectum neurons

description: DeepCAD-RT dataset: zebrafish optic tectum neurons
DOI: 10.6084/m9.figshare.19326611.v1
title: XYZ_training_testing.h5

description: dataset for XYZ pattern classification
DOI: 10.6084/m9.figshare.19326611
title: XYZ_training_testing.h5

description: dataset for XYZ pattern classification
DOI: 10.5281/zenodo.6339753
title: Modelo de Reacción Acrosomal

description: Interacciones del modelo de Reacción Acrosomal en humano.
DOI: 10.5281/zenodo.6339752
title: Modelo de Reacción Acrosomal

description: Interacciones del modelo de Reacción Acrosomal en humano.
DOI: 10.14457/cu.the.2014.1542
title: Life cycle assessment of compressed biomethane gas as second generation biofuel in Thailand
DOI: 10.14457/cu.the.2014.1543
title: Polybenzoxazine sorbents for CO2 capture
DOI: 10.14457/cu.the.2014.1544
title: Preparation of poly(vinyl alcohol) film blended with quaternary ammonium chitosan nanoparticles loaded tetracycline for antibacterial wound dressing
DOI: 10.5519/qd.f85si82j
title: Query on the Natural History Museum Data Portal (data.nhm.ac.uk) (54995 records)
DOI: 10.5517/ccdc.csd.cc286smx
title: CCDC 2091899: Experimental Crystal Structure Determination

description: Related Article: Soumyadeep Chakrabortty, Katharina Konieczny, Bernd H. Müller, Anke Spannenberg, Paul C. J. Kamer, Johannes G. de Vries|2022|Cat.Sci.Tech.|12|1392|doi:10.1039/D1CY02017J
DOI: 10.34820/fk2/cj2q5j/xdrzfg
title: Sound Recording.pptx

description: PPT perkuliahan
DOI: 10.34820/fk2/cj2q5j
title: Replication Data for: Perkuliahan Desain Audio

description: Audio Recording, Editing, Mixing, Mastering, Post-Production
DOI: 10.6084/m9.figshare.19326713
title: circRNA microarray data

description: 来自三名帕金森病 (PD) 患者和三名健康对照者的 circRNA 表达谱。选择3名PD（D1，D2，D3）患者和3名健康对照（C1，C2，C3）进行circRNA表达调查。
DOI: 10.6084/m9.figshare.19326713.v1
title: circRNA microarray data

description: 来自三名帕金森病 (PD) 患者和三名健康对照者的 circRNA 表达谱。选择3名PD（D1，D2，D3）患者和3名健康对照（C1，C2，C3）进行circRNA表达调查。
DOI: 10.6084/m9.figshare.19326964
title: Additional file 1 of Data mining of bulk and single-cell RNA sequencing introduces OBI1-AS1 as an astrocyte marker with possible role in glioma recurrence and progression

description: Additional file 1. Samples information.
DOI: 10.6084/m9.figshare.19326964.v1
title: Additional file 1 of Data mining of bulk and single-cell RNA sequencing introduces OBI1-AS1 as an astrocyte marker with possible role in glioma recurrence and progression

description: Additional file 1. Samples information.
DOI: 10.6084/m9.figshare.19326967.v1
title: Additional file 2 of Data mining of bulk and single-cell RNA sequencing introduces OBI1-AS1 as an astrocyte marker with possible role in glioma recurrence and progression

description: Additional file 2. Complete list of DELncRNAs (LGG vs GBM).
DOI: 10.6084/m9.figshare.19326967
title: Additional file 2 of Data mining of bulk and single-cell RNA sequencing introduces OBI1-AS1 as an astrocyte marker with possible role in glioma recurrence and progression

description: Additional file 2. Complete list of DELncRNAs (LGG vs GBM).
DOI: 10.6084/m9.figshare.19326970.v1
title: Additional file 3 of Data mining of bulk and single-cell RNA sequencing introduces OBI1-AS1 as an astrocyte marker with possible role in glioma recurrence and progression

description: Additional file 3. The result of DEA using all recurrent LGG samples (after recurrence vs before recurrence).
DOI: 10.6084/m9.figshare.19326970
title: Additional file 3 of Data mining of bulk and single-cell RNA sequencing introduces OBI1-AS1 as an astrocyte marker with possible role in glioma recurrence and progression

description: Additional file 3. The result of DEA using all recurrent LGG samples (after recurrence vs before recurrence).
DOI: 10.6084/m9.figshare.19326973
title: Additional file 4 of Data mining of bulk and single-cell RNA sequencing introduces OBI1-AS1 as an astrocyte marker with possible role in glioma recurrence and progression

description: Additional file 4. List of markers for each cluster in Fig.3.
DOI: 10.6084/m9.figshare.19326973.v1
title: Additional file 4 of Data mining of bulk and single-cell RNA sequencing introduces OBI1-AS1 as an astrocyte marker with possible role in glioma recurrence and progression

description: Additional file 4. List of markers for each cluster in Fig.3.
DOI: 10.6084/m9.figshare.19326976
title: Additional file 5 of Data mining of bulk and single-cell RNA sequencing introduces OBI1-AS1 as an astrocyte marker with possible role in glioma recurrence and progression

description: Additional file 5. The result of methylation analysis (LGG vs GBM).
DOI: 10.6084/m9.figshare.19326979.v1
title: Additional file 6 of Data mining of bulk and single-cell RNA sequencing introduces OBI1-AS1 as an astrocyte marker with possible role in glioma recurrence and progression

description: Additional file 6. Result of DEA based on IDH1 mutation status ( IDH1mut vs IDH1wt ).
DOI: 10.6084/m9.figshare.19326979
title: Additional file 6 of Data mining of bulk and single-cell RNA sequencing introduces OBI1-AS1 as an astrocyte marker with possible role in glioma recurrence and progression

description: Additional file 6. Result of DEA based on IDH1 mutation status ( IDH1mut vs IDH1wt ).
DOI: 10.6084/m9.figshare.19326982.v1
title: Additional file 7 of Data mining of bulk and single-cell RNA sequencing introduces OBI1-AS1 as an astrocyte marker with possible role in glioma recurrence and progression

description: Additional file 7. The result of ChIP-seq peak enrichment around OBI1-AS1 promoter.
DOI: 10.6084/m9.figshare.19326976.v1
title: Additional file 5 of Data mining of bulk and single-cell RNA sequencing introduces OBI1-AS1 as an astrocyte marker with possible role in glioma recurrence and progression

description: Additional file 5. The result of methylation analysis (LGG vs GBM).
DOI: 10.6084/m9.figshare.19326982
title: Additional file 7 of Data mining of bulk and single-cell RNA sequencing introduces OBI1-AS1 as an astrocyte marker with possible role in glioma recurrence and progression

description: Additional file 7. The result of ChIP-seq peak enrichment around OBI1-AS1 promoter.
DOI: 10.6084/m9.figshare.19326985
title: Additional file 8 of Data mining of bulk and single-cell RNA sequencing introduces OBI1-AS1 as an astrocyte marker with possible role in glioma recurrence and progression

description: Additional file 8. The result of methylation analysis based on IDH1 mutation status (IDH1mut vs IDH1wt)
DOI: 10.6084/m9.figshare.19326985.v1
title: Additional file 8 of Data mining of bulk and single-cell RNA sequencing introduces OBI1-AS1 as an astrocyte marker with possible role in glioma recurrence and progression

description: Additional file 8. The result of methylation analysis based on IDH1 mutation status (IDH1mut vs IDH1wt)
DOI: 10.6084/m9.figshare.19326988.v1
title: Additional file 9 of Data mining of bulk and single-cell RNA sequencing introduces OBI1-AS1 as an astrocyte marker with possible role in glioma recurrence and progression

description: Additional file 9. Complete list of GO terms.
DOI: 10.6084/m9.figshare.19326988
title: Additional file 9 of Data mining of bulk and single-cell RNA sequencing introduces OBI1-AS1 as an astrocyte marker with possible role in glioma recurrence and progression

description: Additional file 9. Complete list of GO terms.
DOI: 10.6084/m9.figshare.19327046
title: Additional file 3 of The prevalence of liver abnormalities in humans due to Schistosoma japonicum by ultrasonography in China: a meta-analysis

description: Additional file 3: Fig. S1. Sensitivity analysis of the pooled prevalence of schistosomiasis liver abnormalities for all studies.
DOI: 10.6084/m9.figshare.19327046.v1
title: Additional file 3 of The prevalence of liver abnormalities in humans due to Schistosoma japonicum by ultrasonography in China: a meta-analysis

description: Additional file 3: Fig. S1. Sensitivity analysis of the pooled prevalence of schistosomiasis liver abnormalities for all studies.
DOI: 10.6084/m9.figshare.19327018
title: Additional file 12 of Co-expression network analyses of anthocyanin biosynthesis genes in Ruellia (Wild Petunias; Acanthaceae)

description: Additional file 12: Table S1. Results from attempted assembly of structural genes in the ABP in Ruellia. Genes that were assembled in either the leaf (L) or petal (P) tissue shown. Genes that failed to be assembled are shown via an "-". Genes terminated by a premature stop codon are shown via X. The presence of pelargonidins, cyanidins, and/or delphinidins shown via the first three columns.
DOI: 10.6084/m9.figshare.19327018.v1
title: Additional file 12 of Co-expression network analyses of anthocyanin biosynthesis genes in Ruellia (Wild Petunias; Acanthaceae)

description: Additional file 12: Table S1. Results from attempted assembly of structural genes in the ABP in Ruellia. Genes that were assembled in either the leaf (L) or petal (P) tissue shown. Genes that failed to be assembled are shown via an "-". Genes terminated by a premature stop codon are shown via X. The presence of pelargonidins, cyanidins, and/or delphinidins shown via the first three columns.
DOI: 10.6084/m9.figshare.19327021
title: Additional file 13 of Co-expression network analyses of anthocyanin biosynthesis genes in Ruellia (Wild Petunias; Acanthaceae)

description: Additional file 13: Table S2. Custom primers used in the qRT-PCR analysis.
DOI: 10.6084/m9.figshare.19327021.v1
title: Additional file 13 of Co-expression network analyses of anthocyanin biosynthesis genes in Ruellia (Wild Petunias; Acanthaceae)

description: Additional file 13: Table S2. Custom primers used in the qRT-PCR analysis.
DOI: 10.6084/m9.figshare.19327024
title: Additional file 14 of Co-expression network analyses of anthocyanin biosynthesis genes in Ruellia (Wild Petunias; Acanthaceae)

description: Additional file 14: Table S3. Pearson correlation coefficents (r) among identified R2R3 MYBs and ABP structural genes. Values of r ≥ 0.65 are shown in bold and the highest r value for each MYB are highlighted in red.
DOI: 10.6084/m9.figshare.19327024.v1
title: Additional file 14 of Co-expression network analyses of anthocyanin biosynthesis genes in Ruellia (Wild Petunias; Acanthaceae)

description: Additional file 14: Table S3. Pearson correlation coefficents (r) among identified R2R3 MYBs and ABP structural genes. Values of r ≥ 0.65 are shown in bold and the highest r value for each MYB are highlighted in red.
DOI: 10.6084/m9.figshare.19327033
title: Additional file 17 of Co-expression network analyses of anthocyanin biosynthesis genes in Ruellia (Wild Petunias; Acanthaceae)

description: Additional file 17. Table S3. Pearson correlation coefficents (r) among identified R2R3 MYBs and ABP structural genes. Values of r ≥ 0.65 are shown in bold and the highest r value for each MYB are highlighted in red.
DOI: 10.6084/m9.figshare.19327033.v1
title: Additional file 17 of Co-expression network analyses of anthocyanin biosynthesis genes in Ruellia (Wild Petunias; Acanthaceae)

description: Additional file 17. Table S3. Pearson correlation coefficents (r) among identified R2R3 MYBs and ABP structural genes. Values of r ≥ 0.65 are shown in bold and the highest r value for each MYB are highlighted in red.
DOI: 10.6084/m9.figshare.19327090.v1
title: Additional file 2 of A predictive model of genital warts preventive behaviors among women in the south of Iran: application of health belief model

description: Additional file 2. The data file.
DOI: 10.6084/m9.figshare.19327090
title: Additional file 2 of A predictive model of genital warts preventive behaviors among women in the south of Iran: application of health belief model

description: Additional file 2. The data file.
DOI: 10.6084/m9.figshare.19327106
title: Additional file 2 of Comparative analysis of the Mercenaria mercenaria genome provides insights into the diversity of transposable elements and immune molecules in bivalve mollusks

description: Additional file 2: Table S4: GO enrichment analysis. The enrichment analysis, using topGo, of genes identified in M. mercenaria in this study but not found in M. mercenaria YKG (3 first columns) and genes found in M. mercenaria YKG but not in our M. mercenaria assembly (3 last columns). Table S5: Functional annotation and gene duplication. For each gene annotated in this study, gene duplication events (0: “Not duplicated” 1:"dispersed duplication” 2:"proximal duplication” 3:"tandem duplication” 4:"segmental duplication”), Gene Ontology identification and the three first best matches on NR are listed. Table S6: GO enrichment in duplicated genes. GO enrichment analysis using topGO was performed on the genes found duplicated within M. mercenaria genome. Results were sorted by p value. Table S7: Genes expanded in M. mercenaria across Bivalvia. Orthogroups gene counts across 20 genomes of Bivalvia with expanded genes in M. mercenaria. Ave being the mean of copies in each species. Expansion column: 1: genes expanded in M. mercenaria not detected in all other species. 2: Genes with copy numbers higher in M. mercenaria than the mean number of copies in all other species. 3: Genes with copy numbers higher in M. mercenaria than the mean number of copies in all Venerida species. Table S8: TNF containing domain genes. List of all M. mercenaria genes found in orthogroups containing TNF domains. The CDS start position, the type of duplication (0: “Not duplicated” 1:"dispersed duplication” 2:"proximal duplication” 3:"tandem duplication” 4:"segmental duplication”), the orthogroup ID, the best three first matches on NR, the principal and the number of transmembrane domain and the protein length are reported. Colors represent orthogroups used for the phylogenetic tree (Fig. 4).
DOI: 10.6084/m9.figshare.19327106.v1
title: Additional file 2 of Comparative analysis of the Mercenaria mercenaria genome provides insights into the diversity of transposable elements and immune molecules in bivalve mollusks

description: Additional file 2: Table S4: GO enrichment analysis. The enrichment analysis, using topGo, of genes identified in M. mercenaria in this study but not found in M. mercenaria YKG (3 first columns) and genes found in M. mercenaria YKG but not in our M. mercenaria assembly (3 last columns). Table S5: Functional annotation and gene duplication. For each gene annotated in this study, gene duplication events (0: “Not duplicated” 1:"dispersed duplication” 2:"proximal duplication” 3:"tandem duplication” 4:"segmental duplication”), Gene Ontology identification and the three first best matches on NR are listed. Table S6: GO enrichment in duplicated genes. GO enrichment analysis using topGO was performed on the genes found duplicated within M. mercenaria genome. Results were sorted by p value. Table S7: Genes expanded in M. mercenaria across Bivalvia. Orthogroups gene counts across 20 genomes of Bivalvia with expanded genes in M. mercenaria. Ave being the mean of copies in each species. Expansion column: 1: genes expanded in M. mercenaria not detected in all other species. 2: Genes with copy numbers higher in M. mercenaria than the mean number of copies in all other species. 3: Genes with copy numbers higher in M. mercenaria than the mean number of copies in all Venerida species. Table S8: TNF containing domain genes. List of all M. mercenaria genes found in orthogroups containing TNF domains. The CDS start position, the type of duplication (0: “Not duplicated” 1:"dispersed duplication” 2:"proximal duplication” 3:"tandem duplication” 4:"segmental duplication”), the orthogroup ID, the best three first matches on NR, the principal and the number of transmembrane domain and the protein length are reported. Colors represent orthogroups used for the phylogenetic tree (Fig. 4).
DOI: 10.6084/m9.figshare.19327132
title: Additional file 2 of An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile

description: Additional file 2: Table S1. Information of CRC patients used to isolate CTCs. NA: Not Available; CT: Chemotherapy.
DOI: 10.6084/m9.figshare.19327132.v1
title: Additional file 2 of An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile

description: Additional file 2: Table S1. Information of CRC patients used to isolate CTCs. NA: Not Available; CT: Chemotherapy.
DOI: 10.6084/m9.figshare.19327135
title: Additional file 3 of An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile

description: Additional file 3: Table S2. List of compounds used in the screening: drug name, targets Selleckchem catalogue number and doses are reported. Anti-cancer compounds (sheet 1) have been used at a 200 nM concentration, whereas low toxicity compounds (sheet 2) have been used at the indicated doses in order to identify the LD50 value reported in Fig. 5E.
DOI: 10.6084/m9.figshare.19327135.v1
title: Additional file 3 of An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile

description: Additional file 3: Table S2. List of compounds used in the screening: drug name, targets Selleckchem catalogue number and doses are reported. Anti-cancer compounds (sheet 1) have been used at a 200 nM concentration, whereas low toxicity compounds (sheet 2) have been used at the indicated doses in order to identify the LD50 value reported in Fig. 5E.
DOI: 10.6084/m9.figshare.19327138
title: Additional file 4 of An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile

description: Additional file 4: Table S3. List of proteins and raw endpoint values relative to the Proteome Profiler Arrays shown in Fig. 6A.
DOI: 10.6084/m9.figshare.19327138.v1
title: Additional file 4 of An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile

description: Additional file 4: Table S3. List of proteins and raw endpoint values relative to the Proteome Profiler Arrays shown in Fig. 6A.
DOI: 10.6084/m9.figshare.19327124
title: Additional file 10 of A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects

description: Additional file 10: Table S8. Neuropsychological battery performance in MAPT c.1189C&gt;T (p.Pro397Ser) carriers vs non-carriers according to their age groups and clinical diagnosis.
DOI: 10.6084/m9.figshare.19327127
title: Additional file 11 of A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects

description: Additional file 11: Table S9. Family history of dementia and or motor neuron disease from the 566 probands.
DOI: 10.6084/m9.figshare.19327124.v1
title: Additional file 10 of A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects

description: Additional file 10: Table S8. Neuropsychological battery performance in MAPT c.1189C&gt;T (p.Pro397Ser) carriers vs non-carriers according to their age groups and clinical diagnosis.
DOI: 10.6084/m9.figshare.19327127.v1
title: Additional file 11 of A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects

description: Additional file 11: Table S9. Family history of dementia and or motor neuron disease from the 566 probands.
DOI: 10.6084/m9.figshare.19327130.v1
title: Additional file 12 of A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects

description: Additional file 12: Table S10. Additional information of the carriers of Protein Truncating Variants (PVT) and Strictly Damaging variants (SD) in risk conferring genes.
DOI: 10.6084/m9.figshare.19327130
title: Additional file 12 of A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects

description: Additional file 12: Table S10. Additional information of the carriers of Protein Truncating Variants (PVT) and Strictly Damaging variants (SD) in risk conferring genes.
DOI: 10.6084/m9.figshare.19327133
title: Additional file 13 of A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects

description: Additional file 13: Table S11. Homozygosity by descent (HBD) in carriers of disease causing and risk conferring variants.
DOI: 10.6084/m9.figshare.19327133.v1
title: Additional file 13 of A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects

description: Additional file 13: Table S11. Homozygosity by descent (HBD) in carriers of disease causing and risk conferring variants.
DOI: 10.6084/m9.figshare.19327139
title: Additional file 2 of A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects

description: Additional file 2: Table S1. Demographic information of the included cohorts and their respective sub-cohorts.
DOI: 10.6084/m9.figshare.19327139.v1
title: Additional file 2 of A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects

description: Additional file 2: Table S1. Demographic information of the included cohorts and their respective sub-cohorts.
DOI: 10.6084/m9.figshare.19327142
title: Additional file 3 of A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects

description: Additional file 3: Table S2. Demographic information of the probands from included cohorts and their respective sub-cohorts.
DOI: 10.6084/m9.figshare.19327142.v1
title: Additional file 3 of A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects

description: Additional file 3: Table S2. Demographic information of the probands from included cohorts and their respective sub-cohorts.
DOI: 10.6084/m9.figshare.19327145
title: Additional file 4 of A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects

description: Additional file 4: Table S3. GenBank accession numbers for the genes reported in the present study.
DOI: 10.6084/m9.figshare.19327145.v1
title: Additional file 4 of A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects

description: Additional file 4: Table S3. GenBank accession numbers for the genes reported in the present study.
DOI: 10.6084/m9.figshare.19327148
title: Additional file 5 of A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects

description: Additional file 5: Table S4. Mitochondrial haplogroups of the probands.